However, under the current WHO classification, GBM is strictly defined as IDH-wildtype, and IDH-mutant high-grade gliomas are now classified separately as astrocytoma, IDH-mutant, Grades II-IV. This evidence concerns the gene IDH2 and central nervous system cancer.